Parkinson's Disease
Conditions
Keywords
Parkinson's disease, rTMS, Freezing of Gait
Brief summary
This study is a double blind comparative study examining the effectiveness of the rTMS treatment on Freezing of Gait (FOG) phenomenon in patients with Parkinson's disease. We hypothesize that treatment using rTMS stimulation on frontal lobe areas will improve gait quality and decrease the frequency of FOG in patients with Parkinson's disease.
Detailed description
A course of low-frequency repetitive transcranial magnetic stimulation (rTMS) delivered over the supplementary motor area (SMA) improves motor symptoms in patients with Parkinson's disease (PD). The present study is a comparative study that examines the effectiveness of rTMS treatment technique Freezing of Gait (FOG) phenomenon in Parkinson's disease patients. We hypothesize that treatment using rTMS stimulation on frontal areas will decreasing frequency of FOGs in patients with Parkinson's disease and improve gait quality and quality of life.
Interventions
Participants will receive treatment at a frequency of 3 sessions per week for 4 weeks (12 sessions). In each session patient will receive repetitive Transcranial Magnetic Stimulation using a stimulation frequency of 10 Hz for half an hour. The treatment is done by attaching an electromagnetic coil to the scalp using a special hat. Each patient has a personal hat which serves him throughout the entire process. The treatment is performed without anesthesia and patient fully conscious. During the treatment he sits comfortably on a chair, meanwhile the magnetic field passes through the skull into the brain.
DEVICErTMS maintenance
Same treatment as in rTMS treatment intervention, but only once a week for a month
DEVICESham
Participants will receive sham treatment at a frequency of 3 sessions per week for 4 weeks (12 sessions total) for half an hour each session. The treatment is done by attaching an electromagnetic coil to the scalp but without turning on the magnetic field.
DEVICESham maintenance
The same as Sham stimuli intervention, but once a week for a month
Sponsors
Tel-Aviv Sourasky Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
50 Years to 89 Years
Healthy volunteers
No
Inclusion criteria
1. Idiopathic Parkinson's disease (PD), as diagnosed by a neurologist. 2. The mini-mental state examination questionnaire score above 24 points. 3. Suffer from a disabling phenomenon called Freezing of Gait (FoG) (Freezing Of Gait questionnaire score\> = 10) 4. Negative responses to the Preliminary Safety Magnetic Stimulation Treatment questionnaire.
Exclusion criteria
1. Other neurological or psychiatric disorders. 2. Severe personality disorder. 3. High Blood Pressure. 4. History of epilepsy, seizures or convulsions. 5. History of epilepsy or convulsions in first-degree relatives. 6. History of head injury or stroke. 7. Metal remains of the skull or inside the brain (outside the oral cavity). 8. Surgeries including metallic implants or known history of metal particles in the eye, pacemakers, hearing devices transplantation, or medical pumps. 9. Current history of migraines for the last six months. 10. A history of drug or alcohol abuse 11. Other medical research in the time to experiment or three months ahead. -
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in frequency and severity of the freezing of gait phenomenon | One week post intervention | The new version of the Freezing of Gait questionnaire will be used to quantify the frequency and severity of this symptom. The score will be compared to baseline. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Community ambulation | One week post intervention | Will be assessed using 1) the Habitual Physical Activity Questionnaire (HPAQ). It will quantify the type and amount of regular physical activity. 2) A body-worn small lightweight device that will be worn by the subject for 7 days to monitor stepping and physical activity. |
| Changes in endurance | One week post intervention | This measure will be assessed using the 2 minute walk test. The distance walked during 2 minutes will be compared to baseline performance. |
| Balance | One week post intervention | Balance and lower extremity function will be assessed using performance-based measures: (1) The Four Square Step Test (FSST), (2) The Short Physical Performance Battery (SPPB), and (3) The Mini- Balance Evaluation Systems Test (mini-BEST). |
| Immediate changes in blood pressure | Every session, immediately after receiving the treatment | Measuring blood pressure will monitor subjects' autonomic response to the treatment. Measures will be compared before and after receiving the treatment |
| Immediate change in gait function | One week post intervention | Gait speed and variability will be assessed under usual and dual task conditions and while negotiating physical obstacles, using a sensorized 7 meter carpet (PKMAS) and wearable body fixed sensors. These measures will be compared to baseline performance. |
Countries
Israel
Contacts
Primary ContactNir Giladi, MD
Backup ContactAnat Mirelman, PhD
Outcome results
None listed